Nektar therapeutics share price
WebView historical data and performance charts. The technical summary section provides an analysis as to whether Nektar stock is a buy or sell using real time data. Use the tab to select a relevant stock exchange, depending on the stock, you may prefer to view either NASDAQ stock prices or LSE share prices. (ISIN: US6402681083) WebApr 13, 2024 · The stock of Nektar Therapeutics has declined 84.9% in the past year compared with a decrease of 17.9% for the industry. However, the company has seen …
Nektar therapeutics share price
Did you know?
WebGet Nektar Therapeutics (NKTR)'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house. WebNektar Therapeutics company facts, ... Transaction Type Share Price Shares Value; Nov 16, 2024 Sale: Howard W. Robin President & CEO; Director: Disposition $3.57 PER SHARE: 38,014 $135,710:
WebApr 10, 2024 · The stock of Catalyst Pharmaceuticals has risen 116.7% in the past year. Earnings estimates for 2024 have increased from $1.40 per share to $1.46 per share … WebApr 10, 2024 · Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. …
WebApr 13, 2024 · The stock of Nektar Therapeutics has declined 84.9% in the past year compared with a decrease of 17.9% for the industry. However, the company has seen positive estimate revisions. For Nektar ... WebNektar Therapeutics traded at $0.77 this Monday March 27th, increasing $0.05 or 7.31 percent since the previous trading session. Looking back, over the last four weeks, Nektar Therapeutics gained 44.17 percent. Over the last 12 months, its price fell by 86.12 percent. Looking ahead, we forecast Nektar Therapeutics to be priced at 0.70 by the end of this …
WebOn eToro, you can buy $NKTR or other stocks and pay ZERO commission! Follow Nektar Therapeutics share price and get more information. Terms apply.
WebApr 9, 2024 · The Goldman Sachs Group lowered their target price on shares of Nektar Therapeutics from $3.00 to $2.00 and set a “sell” rating for the company in a research note on Monday, February 27th. biontech interviewWebApr 12, 2024 · Nektar Therapeutics ’s (NKTR) 100-Day exponential moving average is 2.05, while Nektar Therapeutics ’s (NKTR) share price is $0.935, making it a Sell. Nektar Therapeutics ’s ( NKTR ) stock price is $0.935 and Nektar Therapeutics ’s ( NKTR ) 50-day simple moving average is 1.74 , creating a Sell signal. biontech investor calendarWebFeb 3, 2024 · Mizuho Securities analyst Mara Goldstein maintained a Hold rating on Nektar Therapeutics (NKTR – Research Report) today and set a price target of $6.00.The company’s shares closed yesterday at ... biontech investmentWebOct 18, 2016 · SAN FRANCISCO, Oct. 18, 2016 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) ("Nektar") today announced the pricing of its previously announced … biontech investorsWebApr 10, 2024 · The Nektar Therapeutics stock price gained 6.57% on the last trading day (Monday, 10th Apr 2024), rising from $0.791 to $0.84. ... Volume fell on the last day by -3 million shares and in total, 4 million shares were … biontech labelWebAccess detailed information about the Nektar Therapeutics (NKTR) Share including Price, Charts, Technical Analysis, Historical data, Nektar Reports and more. biontech investitionWebNektar Therapeutics’s share price is determined by its bid-ask spread, which is the difference between the price that buyers are willing to pay and the price that sellers are willing to accept. Nektar Therapeutics ’s price can fluctuate throughout the course of each trading day—when you buy Nektar Therapeutics through Stash, we execute the market … biontech investing